Glicothera

Glicothera is a Spanish biotechnology company focused on the development of innovative therapies for rare diseases, specifically targeting congenital disorders of glycosylation (CDG). The company leverages a proprietary platform to design and optimize glycan-based molecules that can restore proper glycosylation patterns in patients with genetic deficiencies. By focusing on metabolic pathways and enzymatic regulation, Glicothera aims to provide first-in-class treatments for underserved pediatric populations. Their approach combines expertise in glycobiology and medicinal chemistry to address the underlying biochemical causes of complex multisystemic disorders.